Seaport Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Seaport Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker SPTX.
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial...
Can you invest in Seaport Therapeutics, Inc. Common Stock?
Yes. Seaport Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker SPTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Seaport Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.